Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
BioSpace
Wed, 11/14/18 - 09:56 am
Tags:
Viagra, Pfizer, Cialis, Eli Lilly, erectile dysfunction, cancer, Cardiovascular, drug repurposing
Concert’s initial alopecia data fall short against Pfizer, prompting investor blow back
Endpoints
Tue, 11/13/18 - 09:50 am
Tags:
Concert Pharmaceuticals, alopecia, JAK inhibitors, Pfizer, CTP-543
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
BioCentury
Tue, 11/6/18 - 11:35 am
Tags:
Pfizer, Nektar Therapeutics, NKTR-214, Xtandi, Talzenna, Bavencio, prostate cancer
Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
Fierce Pharma
Sat, 11/3/18 - 04:12 pm
Tags:
Mylan Labs, Pfizer, EpiPens
FDA approves Pfizer's treatment for certain lung cancer patients
Yahoo/Reuters
Sat, 11/3/18 - 12:33 pm
Tags:
Pfizer, FDA, Lorbrena, ALK-positive non-small cell lung cancer
NASH Treatment: Will a Combo Drug Developed by Novartis and Pfizer Make the Cut?
Xtalks
Thu, 11/1/18 - 07:13 pm
Tags:
Pfizer, Novartis, NASH
Pfizer likely to remove lid on drug price increases in January
BioCentury
Tue, 10/30/18 - 11:20 pm
Tags:
Pfizer, drug prices, Pharma CEOs, Ian Read
Pfizer's 3Q profit, up due to tax cut, beats expectations
Yahoo/AP
Tue, 10/30/18 - 07:05 pm
Tags:
Pfizer, earnings, tax cuts
Big Pharma rivals Pfizer and Novartis team up on NASH combo targets
Fierce Biotech
Mon, 10/29/18 - 11:50 am
Tags:
Pfizer, Novartis, NASH, drug development
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Sun, 10/28/18 - 07:42 pm
Tags:
Big Pharma, biosimilars, Novartis, Amgen, Merck, Pfizer, Biogen
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics, Allergan, Pfizer, Clovis Oncology, Acorda Therapeutics, Takeda, Agios Pharmaceuticals, Shire, Teva Pharmaceutical, AbbVie
Pfizer works to get 'wait-and-see' doctors on board the Ibrance train
Fierce Pharma
Fri, 10/26/18 - 11:55 am
Tags:
Pfizer, Ibrance, physicians, breast cancer
Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer
Pharmaceutical Business Review
Fri, 10/26/18 - 09:52 am
Tags:
Daiichi Sankyo, Merck, Pfizer, clinical trials, DS-8201, solid tumors
Bayer plans filings for prostate cancer drug darolutamide
Pharmaforum
Wed, 10/24/18 - 10:09 am
Tags:
Bayer, darolutamide, prostate cancer, Pfizer, JNJ
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
Yahoo/Reuters
Tue, 10/23/18 - 11:09 pm
Tags:
Pfizer, Eli Lilly, osteoarthritis, opioid alternatives, painkillers
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
CP Wire
Tue, 10/23/18 - 01:57 pm
Tags:
Bain Capital, Pfizer, Cerevel Therapeutics, CNS
Tue, 10/23/18 - 10:14 am
Tags:
Pfizer, Bain Capital, Cerevel Therapeutics
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Sun, 10/21/18 - 11:28 pm
Tags:
Pfizer, Bristol-Myers Squibb, kidney cancer, Bavencio
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Tags:
Lilly, Verzenio, breast cancer, Pfizer, Ibrance, Novartis, Kisqali, NICE
Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
Fierce Pharma
Thu, 10/18/18 - 01:07 pm
Tags:
Merck, Keytruda, kidney cancer, Pfizer, Inlyta, Sutent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.